299dated records
Glucagon
- Evidence types
- 4
- Cited sources
- 299
- Source years
- 23
1960–2026 in the selected record set
Navigate the evidence
Peptide research atlas
Explore PeptideScanner’s selected public records by peptide, evidence type, and source date. This is a map of current coverage—not a ranking of importance, quality, safety, or effectiveness.
2625Dated records
41Connected profiles
2632Cited public sources
4Evidence types
Coverage through time
Explore the selected record timeline
Each bar shows how many records in the current public collection carry that source year. Empty years are shown separately as useful coverage gaps—not as evidence that no research occurred.
- 196011 profile · 1 evidence type · 1 cited source
- 198511 profile · 1 evidence type · 1 cited source
- 198811 profile · 1 evidence type · 1 cited source
- 198911 profile · 1 evidence type · 1 cited source
- 199011 profile · 1 evidence type · 1 cited source
- 199311 profile · 1 evidence type · 1 cited source
- 199521 profile · 1 evidence type · 2 cited sources
- 199711 profile · 1 evidence type · 1 cited source
- 199873 profiles · 1 evidence type · 7 cited sources
- 199911 profile · 1 evidence type · 1 cited source
- 200062 profiles · 2 evidence types · 6 cited sources
- 200123 profiles · 1 evidence type · 2 cited sources
- 200243 profiles · 2 evidence types · 4 cited sources
- 2003754 profiles · 2 evidence types · 75 cited sources
- 2004665 profiles · 2 evidence types · 66 cited sources
- 2005215 profiles · 3 evidence types · 21 cited sources
- 2006789 profiles · 3 evidence types · 78 cited sources
- 2007225 profiles · 3 evidence types · 22 cited sources
- 2008217 profiles · 3 evidence types · 21 cited sources
- 2009179 profiles · 3 evidence types · 17 cited sources
- 2010118 profiles · 3 evidence types · 11 cited sources
- 2011148 profiles · 3 evidence types · 14 cited sources
- 2012259 profiles · 3 evidence types · 25 cited sources
- 201314515 profiles · 3 evidence types · 145 cited sources
- 20144011 profiles · 4 evidence types · 40 cited sources
- 20155413 profiles · 3 evidence types · 54 cited sources
- 201611617 profiles · 3 evidence types · 116 cited sources
- 201712620 profiles · 3 evidence types · 126 cited sources
- 20189825 profiles · 3 evidence types · 98 cited sources
- 201912826 profiles · 3 evidence types · 128 cited sources
- 20207022 profiles · 3 evidence types · 70 cited sources
- 20217622 profiles · 4 evidence types · 76 cited sources
- 20227123 profiles · 4 evidence types · 71 cited sources
- 202310123 profiles · 4 evidence types · 101 cited sources
- 202412430 profiles · 3 evidence types · 124 cited sources
- 202518134 profiles · 3 evidence types · 181 cited sources
- 202691639 profiles · 4 evidence types · 923 cited sources
30
No selected dated records currently appear for 1961, 1962, 1963, 1964, 1965, 1966, 1967, 1968, 1969, 1970, 1971, 1972, 1973, 1974, 1975, 1976, 1977, 1978, 1979, 1980, 1981, 1982, 1983, 1984, 1986, 1987, 1991, 1992, 1994, 1996. These years are candidates for future source backfill.
Choose a source lane
What kind of record are you looking for?
Literature metadata1425
39 connected profiles · 1425 cited sources
Open this evidence lane →Clinical trials72132 connected profiles · 721 cited sources
Open this evidence lane →Regulatory45533 connected profiles · 462 cited sources
Open this evidence lane →Safety249 connected profiles · 24 cited sources
Open this evidence lane →Attributed bibliography
Follow publication years and PubMed record types.
PubMed bibliography adds a second, explicitly labeled chronology alongside the metadata-revision archive. Browse source titles, venues, publication dates, and publication types without turning them into PeptideScanner-authored claims.
Attributed registry observations
Follow ClinicalTrials.gov records across registry-update years.
Browse selected retained records by peptide, update year, and historical lifecycle at observation. Registration is not evidence that an intervention is safe or effective.
Exact source-declared connections
Move directly between selected trial and publication records.
Browse structured NCT-to-PMID links declared by PubMed, ClinicalTrials.gov, or both, while retaining the registry’s own reference type and avoiding title or peptide-name inference.
Official regulatory records
Follow each reviewed Drugs@FDA application through its official history.
Browse exact application identifiers, dated AP submissions, source-defined action labels, and official document links without importing document prose or creating treatment claims.
Official Federal Register documents
Follow FDA- and HHS-attributed notices and rules across publication years.
Browse document identity, publication date, type, and exact reviewed peptide-name connections, with every record linked to its official GovInfo PDF and no inferred legal or medical meaning.
Official FDA enforcement reports
Follow dated recall reports tied to exact reviewed applications.
Browse FDA classification, source status, recalling firm, report dates, and source-reported reasons while preserving the non-alert and incomplete-lifecycle boundary.
Source freshness and change
See when every official-source lane was last checked.
Compare committed check dates, latest represented source dates, coverage, cadence declarations, admitted-change receipts, and lane-specific limitations.
Official label version records
Follow DailyMed SPL versions across publication years.
Browse exact version numbers, publication dates, and historical ZIP receipts for 22 reviewed label families without reproducing label text or inferring what changed.
Publication change notices
Carry publisher corrections and errata with the source.
Inspect the bounded Crossref snapshot for DOI-backed publications used in supervised synthesis. A registered notice remains attributed to its source, while an empty check is explicitly not treated as proof that a publication never changed.
Supervised human evidence
Read outcomes alongside populations, limitations, and open questions.
Browse bounded Human Evidence Reviews across therapeutic areas. Every factual sentence is pinned to an accepted source snapshot, with preserved public versions and connected publisher notices.
Most connected
Research hubs with multiple evidence types
These profiles connect records from more than one evidence lane. Counts describe this site’s selected source coverage and should not be interpreted as a score.
232dated records
Semaglutide
- Evidence types
- 4
- Cited sources
- 232
- Source years
- 10
2017–2026 in the selected record set
212dated records
Leuprolide
- Evidence types
- 4
- Cited sources
- 212
- Source years
- 32
1985–2026 in the selected record set
165dated records
Tirzepatide
- Evidence types
- 4
- Cited sources
- 165
- Source years
- 5
2022–2026 in the selected record set
164dated records
Liraglutide
- Evidence types
- 4
- Cited sources
- 164
- Source years
- 17
2009–2026 in the selected record set
157dated records
Octreotide
- Evidence types
- 4
- Cited sources
- 157
- Source years
- 25
1988–2026 in the selected record set
146dated records
Teriparatide
- Evidence types
- 3
- Cited sources
- 146
- Source years
- 24
1999–2026 in the selected record set
116dated records
Exenatide
- Evidence types
- 3
- Cited sources
- 116
- Source years
- 20
2005–2026 in the selected record set
Historical reach
Profiles reaching furthest back in the selected record set
These are starting points for exploring older source records. A longer visible span means PeptideScanner currently connects more source years; it does not mean the underlying research is more complete.
- Glucagon1960–2026299 records across 23 source years
- Leuprolide1985–2026212 records across 32 source years
- Octreotide1988–2026157 records across 25 source years
- Teriparatide1999–2026146 records across 24 source years
- Pramlintide2001–202666 records across 15 source years
- Emideltide2003–202644 records across 13 source years
Recently dated
Latest records in the atlas
Regulatory · August 20, 2026
Federal Register notice 2026-16998
The Federal Register published notice 2026-16998, attributed to FDA and its parent HHS department, on 2026-08-20. Its official title is “Advisory Committee; Endocrinologic and Metabolic Drugs Advisory Committee; Renewal,” and PeptideScanner's exact reviewed identity mapping connects the document to Exenatide.
Regulatory · August 17, 2026
Abaloparatide DailyMed SPL version 19
DailyMed lists Structured Product Labeling version 19 for the reviewed Abaloparatide label family with a published date of 2026-08-17. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents.
Literature metadata · August 15, 2026
Validation of a Pharmacist-Led Semaglutide Prescribing Algorithm for Type 2 Diabetes and Chronic Kidney Disease: Research Letter.
PubMed lists PMID 42602345 in Canadian journal of kidney health and disease as Journal Article, with publication-date metadata of 2026-08-13 (day precision). PeptideScanner associated the retained record with the identity slug semaglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.
SemaglutideSource: PubMed ↗
Literature metadata · August 14, 2026
Geographic Disparities in Glucagon Prescriptions Across North Carolina.
PubMed lists PMID 40513916 in American journal of preventive medicine as Journal Article, with publication-date metadata of 2025-06-11 (day precision). PeptideScanner associated the retained record with the identity slug glucagon. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.
Literature metadata · August 14, 2026
Treatment of obesity with liraglutide in bipolar disorder: a case report.
PubMed lists PMID 42597211 in Frontiers in psychiatry as Case Reports, Journal Article, with publication-date metadata of 2026-07-30 (day precision). PeptideScanner associated the retained record with the identity slug liraglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.
LiraglutideSource: PubMed ↗
Literature metadata · August 14, 2026
Inflammation-mediated facial nodules to compounded tirzepatide.
PubMed lists PMID 42598502 in JAAD case reports as Letter, with publication-date metadata of 2026-06-17 (day precision). PeptideScanner associated the retained record with the identity slug tirzepatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.
TirzepatideSource: PubMed ↗